Meningococcal Vaccines Market Demands, Company Overview, Financial Performances 2030

Meningococcal Vaccines Industry Overview

The global meningococcal vaccines market size was valued at USD 2.88 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 6.2% from 2022 to 2030.

The increasing prevalence of meningitis is one of the major factors expected to drive the market. According to the Centers for Disease Control and Prevention (CDC), around 1.2 million cases of bacterial meningitis are projected to occur globally every year. Moreover, increasing immunization programs, growing awareness about the disease, and increasing R&D activities pertaining to meningococcal vaccines are expected to fuel the market growth during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Meningococcal Vaccines Market

U.S. meningococcal vaccines market size, by type, 2020-2030 (USD Billion)

The overall market experienced a decline in 2020 owing to the COVID-19 pandemic. The net sales of Menactra, Menveo, Nimenrix, Trumenba, and Bexsero were negatively impacted in 2020. However, the market is expected to grow at a positive Y-o-Y growth rate in 2021 due to increasing initiatives by government and regulatory authorities to combat the rising prevalence of meningitis. For instance, in May 2019, the Ministry of Health of Ireland approved MenACWY vaccine to be provided to thousands of teenagers in Ireland, due to the rising prevalence of meningitis in 2018. 

Various campaigns and awareness programs are being organized by government & non-government organizations, such as the National Meningitis Association (NMA), Meningitis Research Foundation of Canada, Meningitis B Action Project, and others. These organizations help in promoting continuous research and new approaches involved in disease prevention. Hence, these factors are anticipated to fuel the meningococcal vaccine market growth in the coming years. 

The presence of non-profit organizations providing support for research projects, training to healthcare professionals, and offering information & help to patients is anticipated to accelerate market growth. For instance, in August 2021, DoSomething.Org and National Foundation for Infectious Diseases (NFID) introduced the "Complete What's Missing Program". The program's goal is to educate young people about the importance of Meningococcal Disease Prevention. 

The presence of phase III vaccines in the pipeline which are expected to be commercialized over the forecast period is anticipated to fuel the market growth. For instance, in June 2020, Pfizer, Inc. initiated phase III clinical trials of PF-06886992, a pentavalent meningococcal vaccine candidate (MenABCWY) to assess & compare the safety, immunogenicity, and tolerability with licensed meningococcal vaccines in adolescents and young adults. Moreover, Menactra, a conjugate vaccine manufactured by Serum Institute of India Pvt. Ltd. is currently in phase III clinical trial. 

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

  • Aptamers Market: The global aptamers market size was valued at USD 1,624.5 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 23.5% from 2022 to 2030. 
  • Intravenous Immunoglobulin Market: The global intravenous immunoglobulin market size was valued at USD 11.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2022 to 2030.  

Market Share Insights

  • September 2021: WHO and its partners announced the first-ever global strategy to defeat meningitis.
  • April 2020: Sanofi received FDA approval for its MenQuadfi Meningococcal Conjugate Vaccine for the prevention of invasive meningococcal disorders in individuals at least two years old. 
  • April 2019: Nimenrix was made available for free as a part of the National Immunization Program (NIP) in Australia for the age group 15 to 19 years.

Key Companies profiled:

Some prominent players in the global meningococcal vaccines market include:

  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Ltd.
  • GlaxoSmithKline plc.
  • Merck & co., Inc.

Order a free sample PDF of the Meningococcal Vaccines Market Intelligence Study, published by Grand View Research.

Comments

Post a Comment

Popular posts from this blog

India Electric Vehicle Market Competitive Landscape Report to 2028

Image
India Electric Vehicle Industry Overview The India electric vehicle market size was valued at USD 220.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 94.4% from 2021 to 2030. The attractive incentives being offered by the Indian government on the production and purchase of electric vehicles to encourage the adoption of electric vehicles are anticipated to drive the growth of the market over the forecast period. The outbreak of the COVID-19 pandemic triggered a significant decline in the overall sales of passenger and commercial vehicles in 2020. However, the sales of electric vehicles in India remained unaffected. The post-lockdown sale of pure and hybrid electric vehicles is a prominent driving factor for the electric vehicle market in India. The stringent GreenHouse gas (GHG) emission norms drafted by the government, such as the Bharat Stage (BS) VI emission standards introduced by India’s Ministry of Road Transport and Highways (MoRTH), are a
Read more

Cyber Security Market 2030 - Advanced Solutions for Modern Businesses

Image
Data breaches, malware, and hacking attempts are all too common, forcing businesses and individuals to prioritize cybersecurity market  trends. The internet has become an essential part of our lives, and with it comes the ever-present threat of cyberattacks. Within the struggles of integrity, privacy, and trust, the domain of cybersecurity thrives with firewalls, encryption keys, and neural networks that safeguard our interconnected existence. The Market Landscape This blog explains the core of the cybersecurity market, examining its growth, challenges, and the valiant defenders who shield the virtual world. Numbers Beyond 0 & 1: The global cyber security market is no mere niche; it’s a thriving ecosystem fueled by relentless innovation and escalating threats. According to recent reports, here are the key figures: In 2023, the market was estimated at a staggering  USD 222.66 billion , growing at a projected compound annual growth rate of 12.3% from 2024 to 2030. By 2030, th
Read more

LiDAR Market Historical Data & Forecasts 2030

Image
LiDAR Industry Overview The global LiDAR market size was valued at USD 1.81 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.8% from 2022 to 2030. The technological advancements in spatial resolution of LiDAR-based digital terrain models are providing better accuracy in applications such as change detection on hillsides, water runoff for agriculture or mining sites, and inland waterways. The growth of the market is attributed to the rising automation in LiDAR to reduce human efforts and increase efficiency. Gather more insights about the market drivers, restrains and growth of the Global LiDAR Market   The rising demand for 3D imagery in application areas such as military & defense, topographical surveys, civil engineering, and corridor mapping is expected to drive the market growth over the forecast period. Textured 3D imagery is applied in applications such as 3D mapping, city planning, and corridor mapping. The installation of advanced
Read more